ES Cell Microvesicles for Somatic Dedifferentiation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for dedifferentiating somatic cells into induced pluripotent stem cells face challenges such as high cancer risk from cell fusion, cell damage from polyethylene glycol or cytotoxic materials, and inefficient cytoplasm delivery, leading to incomplete or imperfect dedifferentiation.
Innovation Solution
The use of embryonic stem cell-derived microvesicles for cytoplasm delivery, which avoids the need for polyethylene glycol or cytotoxic materials and allows for controlled and efficient delivery of cytoplasmic content, enabling stable and effective dedifferentiation of somatic cells.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If cell fusion methods are used to dedifferentiate somatic cells, then dedifferentiation can be achieved, but cancer risk increases due to random division or maintenance in fused state
Solution Approach 1:
The invention segments the embryonic stem cell into smaller functional units - microvesicles containing specific cytoplasmic components (proteins, mRNAs, miRNAs) - and delivers these to somatic cells. This avoids complete cell fusion while still providing the necessary dedifferentiation factors, thereby reducing cancer risk while maintaining dedifferentiation efficacy.
Solution Approach 2:
The invention extracts and isolates specific cytoplasmic components from embryonic stem cells into microvesicles, separating the essential dedifferentiation factors from the entire cell structure. This extraction allows selective delivery of beneficial components without introducing harmful elements associated with complete cell fusion.
2Productivity
If polyethylene glycol is used to induce cell fusion, then fusion efficiency improves, but cell damage increases due to cytotoxic effects
Solution Approach 1:
The invention uses microvesicles as intermediary carriers to transfer cytoplasmic content from embryonic stem cells to somatic cells. This intermediary approach eliminates the need for polyethylene glycol-induced cell fusion, achieving efficient content delivery without the cytotoxic side effects of PEG.
3Ease of operation
If cytoplasm is delivered using streptolysin treatment, then cell membrane permeability increases for cytoplasm insertion, but cell viability decreases due to cytotoxic material
Solution Approach 1:
The invention employs microvesicles as disposable delivery vehicles that naturally fuse with target cell membranes without requiring cytotoxic agents like streptolysin. The microvesicles self-destruct after delivering their cargo, achieving easy cytoplasm delivery while preserving cell viability.
4Reliability
If mRNA delivery method is used to introduce dedifferentiation factors, then gene insertion risks are reduced, but dedifferentiation efficiency decreases due to mRNA degradation
Solution Approach 1:
The invention changes the physical state and delivery parameters of genetic material by packaging mRNAs and other dedifferentiation factors within protected microvesicle structures. This parameter change (from naked mRNA to vesicle-enclosed mRNA) simultaneously improves stability against degradation and maintains high dedifferentiation efficiency upon delivery.
5Object-affected harmful factors
If protein delivery method is used to avoid immune response, then safety improves, but dedifferentiation completeness decreases due to insufficient factors
Solution Approach 1:
The invention creates multi-functional microvesicles that simultaneously deliver multiple types of dedifferentiation factors (proteins, mRNAs, miRNAs, and other cytoplasmic components) in a single treatment. This universal delivery system achieves complete dedifferentiation while maintaining safety by avoiding viral vectors and extensive genome manipulation.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This method enables efficient and stable dedifferentiation of somatic cells into induced pluripotent stem cells with reduced side effects and improved delivery efficiency, allowing for potential in-vivo applications and the development of cell therapy products with varied immunocompatibilities.
Implementation Method 1
a cytoplasm delivery method using fusion of microvesicles
Data Source
Figure 1~2
Figure 3~4
Figure 5~6
AI summary
Provided is a method of dedifferentiating somatic cells using embryonic stem cell-derived microvesicles. Particularly, a method of preparing induced pluripotent stem cells by treating a composition including embryonic stem cell-derived microvesicles to the somatic cells. According to the method of preparing induced pluripotent stem cells, the dedifferentiation of the somatic cells may be efficiently performed without side effects using the embryonic stem cell-derived microvesicles, and moreover, the method is expected to be very useful in developing a cell therapy product having immunocompatibilities by individuals.